HBSP (USA)
-
Chobani: Growing A Live and Active Culture (Abridged)
Margolis, Joshua D.; Preble, MatthewCase HBS-414046-ELeadership and People ManagementHamdi Ulukaya, CEO of the Greek yogurt company Chobani, Inc., was reflecting on what explained his young company's meteoric rise. The company held over half of the U.S. Greek yogurt market, and nearly 20% of the total yogurt market. The company's innovative approach to product design, sales, marketing, and communication had made its yogurt a hit with consumers, and its entrepreneurial and innovative culture made it popular with its employees. But...Starting at €8.20
-
Kids & Company in 2018
Groysberg, Boris; Preble, MatthewCase HBS-419054-EStrategyThis case reveals to readers what has transpired at Kids & Company in the year following the decision point presented in Kids & Company: Entering the U.S. (case 418-011).Starting at €8.20
-
Disrupting the Meat Industry: Tissue Culture Beef
Alvarez, Jose B.; Preble, MatthewCase HBS-515001-EMarketingDr. Mark Post and his team at Maastricht University were perfecting their tissue culture beef product-made entirely from muscle grown in his lab-to give it the same taste, texture and appearance of a traditional beef hamburger. A previous iteration of this product had been taste tested live, with good results, and Sergey Brin, a co-founder of Google, had provided Post with much of the funding to make the burgers. The next step was to form an inde...Starting at €8.20
-
Kathy Giusti and the Multiple Myeloma Research Foundation
Hamermesh, Richard G.; Margolis, Joshua D.; Preble, MatthewCase HBS-814026-EService and Operations ManagementWhat do you do when your rising professional career is cut short by an unexpected cancer diagnosis? Kathy Giusti shifted careers, built a new organization that transformed how cancer research is done, and now faces the challenge of sustaining the organization and its funding for its newest venture. Since she was first diagnosed with multiple myeloma (MM) in 1996, Giusti had led an effort to better understand and treat the disease. She had co-fou...Starting at €8.20
-
Viterra
Goldberg, Ray A.; Preble, MatthewCase HBS-913401-EService and Operations ManagementAs Mayo Schmidt's tenure as CEO of the Canadian-based agribusiness Viterra wound down before its sale to the Swiss-based commodity company Glencore, he reflected on his tenure, which had seen the firm grow from a Canadian-focused agricultural cooperative to an international agribusiness with operations across the globe, including significant operations in Australia. Now he wondered: What would the future hold for agriculture?Starting at €8.20
-
Kids & Company: Entering the U.S.
Groysberg, Boris; Preble, Matthew; Connolly Baden, KatherineCase HBS-418011-EStrategyIn April 2017, Victoria Sopik and Jennifer Nashmi, CEO and CFO (respectively) of Kids & Company, a Canadian childcare provider that they had co-founded in the early 2000s and developed into a nearly 100-unit enterprise, are discussing how the company should proceed with its planned U.S. expansion. Kids & Company already has five U.S. childcare centers in and around Chicago, Illinois, and one under construction in Boston, Massachusetts, but before...Starting at €8.20
-
IdentiGEN
Goldberg, Ray A.; Preble, MatthewCase HBS-914408-EService and Operations ManagementCiaran Meghen and Ronan Loftus, co-founders of IdentiGEN (an Irish company that had created a unique service called DNA TraceBack to help customers identify and trace meat products), were discussing the company's future. The recent crisis over beef products being contaminated with horsemeat in Europe had generated strong demand for IdentiGEN's services. But more than this, DNA TraceBack gave customers strong insight into their operations to ensur...Starting at €8.20
-
The "Wonder Drug" that Killed Babies
Krieger, Joshua Lev; Nicholas, Tom; Preble, MatthewCase HBS-818044-EEconomicsIn the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children may have been affected. Just a handful of these children were born in the U.S., where safety concerns were raised by Dr. Frances Oldham Kelsey, the medical officer handling the thali...Starting at €8.20